Cell Cycle Kinases as Therapeutic Targets for Cancer
Sbarro Health Research Organization (SHRO)A featured article in the July 2009 online issue of Nature Reviews/Drug Discovery that explores the prospects and progress of synthetic inhibitors to target cell cycle kinases in cancer forecasts that "novel compounds with increased potency, improved kinase specificity and favorable drug like properties will soon be available for clinical evaluation."